The Federal Council of Pharmacy (CFF) sees with extreme concern the lack of medicines essential to the quality of care and the maintenance of the lives of critically ill patients, with Covid-19 and other pathologies, such as autoimmune diseases, treated with some of these drugs, scarce or unavailable due to the pandemic.

Information from pharmacists working in hospitals and other health services in different parts of the country, as well as public demonstrations by state and municipal health secretaries and the pharmaceutical industry itself, evidence the shortage of neuromuscular blockers, sedatives and other drugs used in intensive care. , like midazolan , essential for a humanized and safe intubation; immunoglobulin , essential for maintaining the life of patients with diseases such as Guillain-Barré Syndrome; tocilizumab , indicated to alleviate the signs and symptoms of rheumatoid arthritis. In these last two cases, in particular, the use of these drugs has no scientific basis for effectiveness so far.

The CFF reiterates to society that it respects measures such as the use of masks and social distance , aiming at reducing the overload of health services; demands from the authorities that all possible measures are taken to ensure that the population is immunized as soon as possible; and it calls for the rational use of medicines , so that the pandemic does not also make victims among people who have not even contracted the coronavirus, but have other diseases as serious as Covid-19.

Maria Isabel
Advisory Board – CFF
isabel@cff.org.br
(61) 3878-8758 / (61) 3878-8758 / (61) 99335-8484